Unknown

Dataset Information

0

PARP-1 inhibition as a targeted strategy to treat Ewing's sarcoma.


ABSTRACT: Ewing's sarcoma family of tumors (ESFT) refers to aggressive malignancies which frequently harbor characteristic EWS-FLI1 or EWS-ERG genomic fusions. Here, we report that these fusion products interact with the DNA damage response protein and transcriptional coregulator PARP-1. ESFT cells, primary tumor xenografts, and tumor metastases were all highly sensitive to PARP1 inhibition. Addition of a PARP1 inhibitor to the second-line chemotherapeutic agent temozolamide resulted in complete responses of all treated tumors in an EWS-FLI1-driven mouse xenograft model of ESFT. Mechanistic investigations revealed that DNA damage induced by expression of EWS-FLI1 or EWS-ERG fusion genes was potentiated by PARP1 inhibition in ESFT cell lines. Notably, EWS-FLI1 fusion genes acted in a positive feedback loop to maintain the expression of PARP1, which was required for EWS-FLI-mediated transcription, thereby enforcing oncogene-dependent sensitivity to PARP-1 inhibition. Together, our findings offer a strong preclinical rationale to target the EWS-FLI1:PARP1 intersection as a therapeutic strategy to improve the treatment of ESFTs.

SUBMITTER: Brenner JC 

PROVIDER: S-EPMC3319786 | biostudies-literature | 2012 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications


Ewing's sarcoma family of tumors (ESFT) refers to aggressive malignancies which frequently harbor characteristic EWS-FLI1 or EWS-ERG genomic fusions. Here, we report that these fusion products interact with the DNA damage response protein and transcriptional coregulator PARP-1. ESFT cells, primary tumor xenografts, and tumor metastases were all highly sensitive to PARP1 inhibition. Addition of a PARP1 inhibitor to the second-line chemotherapeutic agent temozolamide resulted in complete responses  ...[more]

Similar Datasets

| S-EPMC2968715 | biostudies-literature
| S-EPMC4624427 | biostudies-literature
| S-EPMC7981928 | biostudies-literature
| S-EPMC6984994 | biostudies-literature
| S-EPMC5639709 | biostudies-literature
| S-EPMC3893930 | biostudies-literature
| S-EPMC10374484 | biostudies-literature
| S-EPMC3215445 | biostudies-other
| S-EPMC4397982 | biostudies-literature
| S-EPMC8080453 | biostudies-literature